Author | Peter Schmid, MD | OncLive

Author | Peter Schmid, MD

Articles

Dr. Schmid on Activity With Neoadjuvant Pembrolizumab in TNBC

January 21, 2020

Video

Peter Schmid, MD, PhD, discusses the benefit of pembrolizumab when added to neoadjuvant chemotherapy in patients with triple-negative breast cancer.

x